Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Pfizer Paid $896 Million in Prempro Settlements
FDAnews Drug Daily Bulletin
June 20, 2012
| Vol. 9 No. 121
Pfizer Paid $896 Million in Prempro Settlements
Pfizer has paid $896 million to resolve about 60 percent of the cases alleging its menopause drugs caused cancer in women, the drugmaker said in a securities filing.
Businessweek
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Mylan Launches Generic Tricor Tablets
Is the FDA Approving too Many Drugs Starting with X and Z?
Court Rejects Merck Deal Over Vioxx
Citizens in Poor EU States Can’t Afford Medicines, Health Promoters Say